Mahindra Q3 profit rises 12 pct as tractor sales soar
MUMBAI (Reuters) - Mahindra & Mahindra Ltd (MAHM.NS), India's biggest utility vehicle maker, posted a 12 percent rise in quarterly profit, in line with analyst estimates as strong tractor sales offset slowing demand for passenger and commercial vehicles.
Mahindra's automotive division, which includes sport-utility vehicles, trucks and buses, has been hit by high interest rates and fuel costs in a slowing economy.
But the tractor business has reaped the benefits of strong rains last year that put more money in the hands of farmers.
Standalone profit rose to 9.34 billion rupees in the fiscal third quarter ended in December from 8.36 billion rupees a year earlier. Net sales fell 2 percent to 104.05 billion rupees at Mahindra, also the world's largest tractor company by sales volume.
Analysts had, on average, forecast a profit of 9.39 billion rupees, according to Thomson Reuters I/B/E/S.
Mahindra's domestic tractor sales jumped 22 percent during the quarter. But SUV sales fell by about 23 percent.
A rise in excise duty on SUVs, increased competition and a preference among car buyers for smaller SUVs have hurt the company, whose market share in the utility vehicle segment fell to 41 percent at the end of December from nearly 48 percent a year ago, according to industry data.
The company hopes to recoup its market share in 2015, when it expects to launch two compact SUVs, said Pawan Goenka, president of its automotive and farm equipment businesses.
(Reporting by Aradhana Aravindan; editing by Tom Pfeiffer)
- Tweet this
- Share this
- Digg this
- In his native Alabama, Apple CEO's announcement he is gay prompts discomfort for some
- Islamic State fighters kill 220 Iraqis from tribe that opposed them
- Xiaomi moves into third place in global smartphone war
- UPDATE 5-Bike-riding U.S. nurse defies Ebola quarantine, on collision course with governor
- Nurse defies Ebola quarantine with bike ride; negotiations fail |
India's universal health plan that aims to offer guaranteed benefits to a sixth of the world's population will cost an estimated 1.6 trillion rupees ($26 billion) over the next four years, a senior health ministry official said. Full Article